Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuanli Tang

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Drug Design, Development and Therapy|February 26, 2020
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 SignalingJin Yu, Caifeng Zhu, Jiazhen Yin, et al.
International Immunopharmacology|July 16, 2023
Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signalingYuewen Tang, Feng Wan, Xuanli Tang, et al.
Frontiers in Immunology|June 10, 2025
Primary Sjögren's syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case reportZhi-Yu Duan, Guang-Yan Cai, FengKun Chen, et al.
Diagnostic Pathology|July 2, 2015
Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritisXuanli Tang, Bin Zhu, Riping Chen, et al.
Lupus Science & Medicine|December 28, 2023
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathyTian Ye, Mengya Jiang, Xueyan Zeng, et al.
European Journal of Medical Genetics|October 29, 2017
THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1Fujun Lin, Dan Zhang, Juan Chang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 20, 2024
Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic NephropathyYinfeng Chen, Xiaying Wang, Jie Min, et al.
BMC Nephrology|May 29, 2026
Clinicopathological characteristics and renal outcomes of IgA nephropathy in systemic lupus erythematosus: a case report and systematic literature reviewXiXi Zhao, ZhenZhen Li, GuangYan Cai, et al.
The Journal of Pathology. Clinical Research|November 29, 2025
A membranous nephropathy variant mimicking minimal change diseaseChuqi Pan, Silin Xiang, Mengya Jiang, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
The Rare Occurrence of Tissue PLA2R-Positive Membranous Nephropathy in a Patient With Sjögren's Syndrome and Renal Tubular AcidosisChengli Lou, Xuanli Tang, Yijing Zhou, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|February 26, 2020
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 SignalingJin Yu, Caifeng Zhu, Jiazhen Yin, et al.
International Immunopharmacology|July 16, 2023
Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signalingYuewen Tang, Feng Wan, Xuanli Tang, et al.
Frontiers in Immunology|June 10, 2025
Primary Sjögren's syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case reportZhi-Yu Duan, Guang-Yan Cai, FengKun Chen, et al.
Diagnostic Pathology|July 2, 2015
Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritisXuanli Tang, Bin Zhu, Riping Chen, et al.
Lupus Science & Medicine|December 28, 2023
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathyTian Ye, Mengya Jiang, Xueyan Zeng, et al.
European Journal of Medical Genetics|October 29, 2017
THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1Fujun Lin, Dan Zhang, Juan Chang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 20, 2024
Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic NephropathyYinfeng Chen, Xiaying Wang, Jie Min, et al.
BMC Nephrology|May 29, 2026
Clinicopathological characteristics and renal outcomes of IgA nephropathy in systemic lupus erythematosus: a case report and systematic literature reviewXiXi Zhao, ZhenZhen Li, GuangYan Cai, et al.
The Journal of Pathology. Clinical Research|November 29, 2025
A membranous nephropathy variant mimicking minimal change diseaseChuqi Pan, Silin Xiang, Mengya Jiang, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
The Rare Occurrence of Tissue PLA2R-Positive Membranous Nephropathy in a Patient With Sjögren's Syndrome and Renal Tubular AcidosisChengli Lou, Xuanli Tang, Yijing Zhou, et al.
Pageof 3